Changing trends in perinatal outcomes of placenta accreta spectrum: a comparative analysis of cesarean hysterectomy cases in Southern Iran over a decade Authors: Shaghayegh Moradi Alamdarloo, Hamide Barzegar, Zahrasadat Purnajafi, Khadije Bazrafshan, Fatemeh Amirmoezi, Fatemeh Shariati nia, Alimohammad Keshtvarz Hesam Abadi, Zahra Oveisi, Homeira Vafaei Cisakht, Nasrin Asadi, Atefe Hashemi Published: 2026 ABSTRACT AbstractBackgroundPlacenta accreta spectrum (PAS) is a severe obstetric condition associated with substantial maternal and neonatal morbidity. This study aimed to evaluate a five-year experience of PAS management in a tertiary referral center and compare outcomes with those from a preceding five-year period.Methodthis retrospective cohort study was conducted at hospitals affiliated with Shiraz University of Medical Sciences, a tertiary referral center in southern Iran. Pregnant women diagnosed with PAS between January 2020 and December 2024, compared with a historical cohort from January 2015 to December 2019. Clinical and operative data of PAS cases were reviewed. Maternal morbidity and mortality were defined as primary outcomes, while operative characteristics, intraoperative complications, and neonatal outcomes were secondary outcomes. Statistical analyses were performed using SPSS software, with Mann–Whitney and Chi-square tests applied for inter-period comparisons. Maternal morbidity and mortality, operative blood loss, intraoperative complications, gestational age at diagnosis and delivery, and neonatal outcomes were assessed.ResultsOf 325 PAS cases, 300 women underwent hysterectomy and were included in the analysis. The mean gestational age at operation was 31.16 ± 6.16 weeks, and 97% had a prior cesarean section. PAS was diagnosed before 14 weeks in 5%, between 14 and 28 weeks in 41%, and after 28 weeks in 54% of cases. Emergency surgery was required in 18.3%. Mean intraoperative blood loss was 2119.76 ± 1612.93 mL and was significantly higher in placenta percreta (p < 0.001). Bladder injury occurred in 23%, and 79% required packed cell transfusion. Neonatal survival was 83.7%, with 74.7% admitted to the NICU. Compared with the earlier cohort, gestational age at diagnosis was significantly earlier, hospital stay was shorter, and fifth-minute Apgar scores were higher (all p < 0.001).ConclusionsEnhanced prenatal diagnosis and multidisciplinary management have improved maternal and neonatal outcomes in PAS over recent years.Keywords: Placenta accreta, Placenta accreta spectrum, Morbidity, Cesarean section, Neonate, Maternal outcome, Neonatal outcome, Hysterectomy Background Placenta accreta spectrum (PAS) disorders are serious pregnancy complications caused by abnormal adherence of chorionic villi to the myometrium due to defective decidualization [1]. This defect in the decidua basalis allows abnormal trophoblastic invasion into the myometrium, leading to varying degrees of placental invasion [2]. Based on the depth of invasion, PAS is classified into placenta accreta (villi attached to the myometrium), increta (villi invading the myometrium), and percreta (villi penetrating the uterine serosa and sometimes adjacent organs such as the bladder) [3]. The incidence of PAS has risen sharply in recent decades, closely paralleling the global increase in cesarean section (CS) rates. Silver et al. demonstrated in a large multicenter study that the risk of PAS escalates from 3% after the first cesarean delivery to 11% after the second, and further increases to 40%, 61%, and 67% after the third, fourth, and fifth cesarean deliveries, respectively [4]. This trend is particularly concerning in light of recent global estimates by Betrán et al. showing that approximately 21.1% of all births worldwide were delivered by CS in 2018, with projections suggesting this rate may rise to nearly 28.5% by 2030 [5]. Ultrasound plays a central role in the diagnosis of PAS, particularly among women with a low-lying placenta or placenta previa and a history of uterine surgery. As a low-cost and widely accessible modality, it serves as the first-line tool for prenatal detection of PAS [6]. Accurate antenatal diagnosis allows for optimal planning of delivery, ensuring appropriate timing, multidisciplinary management, and improved maternal and neonatal outcomes [6]. While sonographic indicators of PAS can occasionally be detected as early as the first trimester, the majority of cases are identified during the second or third trimester when characteristic features become more apparent [7]. Early prenatal diagnosis of PAS is crucial for ensuring optimal delivery planning and minimizing maternal morbidity [8]. Studies have shown that women with a confirmed antenatal diagnosis who undergo planned cesarean hysterectomy at 34–35 weeks, without attempting placental removal, experience significantly lower blood loss and reduced transfusion requirements compared to those diagnosed intrapartum [9]. Prenatal identification also enables referral to tertiary centers equipped with multidisciplinary teams—comprising obstetricians, anesthesiologists, interventional radiologists, urologists, and vascular surgeons—along with access to essential resources such as intensive care units and blood banks. Deliveries in such specialized centers have been consistently associated with improved outcomes and reduced maternal complications [10]. Despite advances in prenatal imaging and multidisciplinary care, there remains limited longitudinal data assessing how improved diagnostic and management strategies have influenced maternal and neonatal outcomes in PAS, particularly in referral centers of developing regions. Evaluating these changes over time is crucial to determine the real-world impact of evolving clinical practices. Therefore, this study aimed to analyze the clinical characteristics, management approaches, and outcomes of PAS cases over the past five years in our tertiary referral center and to compare them with findings from our previous five-year cohort, highlighting trends in diagnosis timing, surgical morbidity, and perinatal outcomes. Methods Study design and setting This retrospective cohort study was conducted at the Department of Obstetrics and Gynecology, Shiraz University of Medical Sciences (SUMS), tertiary referral center in southern Iran.The study included all pregnant women with a confirmed diagnosis of PAS disorders who underwent pregnancy termination and hysterectomy at hospitals affiliated with SUMS between January 2020 and December 2024 . The inclusion criteria comprised all pregnant women with a confirmed diagnosis of placenta accreta, increta, or percreta, as verified by a pathologist following cesarean hysterectomy. The exclusion criteria were patients who underwent conservative management (i.e., those who did not undergo hysterectomy) and those with unavailable or incomplete medical records due to transfer to another center. Study population and data sources Two categories of patients were included: women who were admitted for obstetric indications other than PAS and were subsequently diagnosed intraoperatively with PAS, and those who were prenatally diagnosed with PAS through ultrasonography or magnetic resonance imaging and referred to our tertiary centers for termination of pregnancy. Following delivery, all surgical specimens were examined in the pathology department, and an expert pathologist confirmed the diagnosis of the PAS subtype. Data collection Data were collected using a structured data collection form that included the following variables: demographic and clinical characteristics such as patient identification number, age, obstetric, gynecologic, medical, and surgical history, as well as gestational age at admission; risk factors including gravidity, number of previous cesarean sections, history of dilation and curettage (D&C), myomectomy, and other uterine surgeries; prenatal imaging findings such as loss of the retroplacental clear zone, myometrial thinning, multiple placental lacunae, subplacental hypervascularity, turbulent flow in lacunae, bladder wall interruption, maximum placental thickness, and presence of placenta previa; operative characteristics including estimated blood loss, number of transfused blood products, duration of hospitalization, intensive care unit (ICU) admission were recorded. Both cohorts were derived from the same tertiary referral center and were evaluated using identical inclusion criteria, diagnostic definitions, and institutional management protocols to ensure consistency across the two study periods. Composite maternal morbidity was defined as the occurrence of one or more of the following: massive transfusion, bladder or ureteral injury, or maternal death. Massive transfusion was defined as the transfusion of ≥ 10 units of packed red blood cells within 24 h. Urinary tract injury was categorized as cystotomy, ureteral transection, or serosal tear, with details on the need for surgical repair or ureteral stenting recorded.and intraoperative or postoperative complications such as bowel, bladder, or ureteral injury, wound infection, postoperative ileus, and maternal mortality; and neonatal outcomes including Apgar scores at 1 and 5 min, need for neonatal intensive care unit (NICU) admission, birth weight, gestational age at delivery, and cause of admission. Cases operated before fetal viability (< 24 weeks), such as cesarean scar PAS requiring hysterectomy, were included in maternal outcome analyses but excluded from perinatal and neonatal outcome assessments. Management protocol All patients were managed according to institutional protocols through a multidisciplinary team approach. The planned delivery window for patients with suspected PAS was 34–35+ 6 weeks of gestation. Upon admission by the perinatology service, consultations were performed with specialists in critical care, urology, and neonatology. Additional consultations with gynecologic oncologists and vascular surgeons were requested when indicated based on imaging or laboratory findings. All surgeries were performed under general anesthesia, and tranexamic acid was routinely administered as part of the standard protocol for PAS surgeries in our center. According to the institutional protocol, antenatal corticosteroids (betamethasone) were routinely administered to women at risk of preterm delivery, particularly in cases of planned delivery before 36 weeks of gestation, to promote fetal lung maturation. Ethical considerations Written informed consent was obtained from all participants whose data were included in this study. The study protocol was approved by the Ethics Committee of Shiraz University of Medical Sciences, and all procedures conformed to the principles of the Declaration of Helsinki. ( IR.SUMS.MED.REC.1403.454) Statistical analysis Continuous variables were summarized as mean ± standard deviation (SD), median (Interquartile Range), while categorical variables were expressed as frequency and percentage. The normality of the data distribution was assessed using the Kolmogorov–Smirnov test. For comparisons of categorical variables, the Chi-square test or Fisher’s exact test was used, as appropriate. To evaluate associations between quantitative and qualitative variables, the Mann–Whitney U test (for two groups) and the Kruskal–Wallis test (for more than two groups) were applied. All analyses were performed using the Statistical Package for the Social Sciences (SPSS, version 23.0; IBM Corp., Chicago, IL, USA). A p-value of < 0.05 was considered statistically significant. Results Maternal characteristics A total of 243,610 deliveries were recorded, of which 146,653 were cesarean sections. Among these, PAS cases were identified exclusively by pathology-confirmed invasive placentation after delivery, resulting in 325 verified cases. This corresponds to an incidence rate of approximately 1.33 per 1,000 deliveries (95% CI: 1.19–1.48) and 2.22 per 1,000 cesarean Sect. (95% CI: 1.98–2.47)Of them, 10 cases were excluded due to incomplete data, 15 underwent conservative (uterus-preserving) management, and the remaining 300 underwent hysterectomy as the definitive treatment and were included in this study (Fig. 1). Figure 2 depicts the trend of PAS during the study period. Flowchart showing the selection process of women with placenta accreta spectrum disorders included in the study. Trend of placenta accreta spectrum incidence per 1,000 deliveries and per 1,000 cesarean sections in hospitals affiliated with Shiraz University of Medical Sciences from 2020 to 2024 The mean maternal age was 34.67 ± 4.38 years (range: 23–48). 132 (44%) were more than 35 years. Two (0.6%) pregnancies were conceived via in vitro fertilization (IVF), and the others were spontaneous. The mean gestational age (GA) at operation was 31.16 ± 6.16 weeks (range: 5–40).Among the included cases, 36 (12%) of women underwent hysterectomy before 24 weeks of gestation. One case operated at 5 weeks’ gestation was initially diagnosed as an ectopic pregnancy and was intraoperatively confirmed to be a cesarean scar pregnancy. Regarding parity, the mean gravidity was 3.87 ± 1.56 (range: 1–14), the mean number of live births was 2.12 ± 1.08 (range: 0–6), abortions 0.69 ± 1.09 (range: 0–10), and stillbirths 0.17 ± 0.50 (range: 0–4). Table 1 depicts the maternal characteristics. Table 1Demographic and obstetric characteristics of study populationVariableMaternal age (years) (Mean ± SD)34.67 ± 4.38Previous cesarean section (n(%)) 09(3) 193(31) 2118(34.3) 359(14.7) 420(6.7) 51(0.3)Previous D & C(n(%)) 0255(85) 138(12.7) 26(2) 31(0.3)Myomectomy and other uterine surgeries(n(%))1(0.03)Pre-operation diagnosis*(n(%)) Accreta170(56.7) Accreta and previa126(42) Previa3(1) Ectopic pregnancy1(0.3)GA at diagnosis (week)(n(%)) < 14 weeks15(5) 14–28 weeks123(41) > 28 weeks162(54)Pathologic diagnosis(n(%)) Accreta137(45.7) Increta86(28.7) Precreta77(25.7)Mean ±SD; N (%)D & C Dilatation and Curettage, GA Gestational Age, PAS Placenta Accreta Spectrum*The preoperative diagnosis was established using ultrasonography or magnetic resonance imaging (MRI) Demographic and obstetric characteristics of study population Mean ±SD; N (%) D & C Dilatation and Curettage, GA Gestational Age, PAS Placenta Accreta Spectrum *The preoperative diagnosis was established using ultrasonography or magnetic resonance imaging (MRI) As shown in Table 1, nine women had no history of cesarean section. Among them, one had undergone a single dilatation and curettage (D&C) procedure. Regarding parity, four of these women were gravida 4, two were gravida 3, three were gravida 2, and one was gravida 1. Operative characteristics and maternal outcomes The duration of preoperative hospitalization ranged from 0 to 70 days, with a median of 4 days, and a mean of 9.37 ± 12.49 days. The mean postoperative hospital stay was 3.74 ± 2.25 days (range: 1–15, median 3), and the mean ICU stay was 1.84 ± 1.31 days (range: 0–10, median 2). Most women required blood product transfusions during surgery. The mean number of transfused units was 3.79 ± 3.20 for packed red blood cells, 4.12 ± 2.28 for fresh frozen plasma (FFP), and 4.15 ± 2.27 for platelets, with ranges of 1–16, 1–15, and 1–15 units, respectively. Table 2 presents the details of operative findings. Table 2Descriptive analysis of operative characteristics and maternal outcomeVariableNumber (%)Reason for admission(n(%)) Planned admission for suspected PAS (elective referral)180(60) Vaginal bleeding83(27.7) PLP7(2.3) PROM5(1.7) Others25(8.3)Blood loss(ml)(n(%)) ≤ 1000105(35) 1000–200076(25.3) 2000–300030(10) ≥ 300089(29.7)Packed cell transfusion(n(%))237(79)FFP transfusion(n(%))106(35.3)PLT transfusion(n(%))98(32.7)Complications during surgery(n(%)) Bladder injury69(23) Ureter injury13(4.3) Bladder and ureter injury1(0.3) Bowel injury1(0.3) Readmission (n(%))9(3)GA Gestational Age, FFP Fresh Frozen Plasma, PLT Platelet, PAS Placenta Accreta Spectrum, PLP Preterm Labor Pain, PROM Premature Rupture of Membranes Descriptive analysis of operative characteristics and maternal outcome GA Gestational Age, FFP Fresh Frozen Plasma, PLT Platelet, PAS Placenta Accreta Spectrum, PLP Preterm Labor Pain, PROM Premature Rupture of Membranes Maternal mortality occurred in 1 of 300 women (0.3%) who underwent hysterectomy. Emergency surgery was done in 55(18.3%). The mean estimated blood loss differed significantly among the three types of placental invasion. In cases of placenta accreta, increta, and percreta, the mean bleeding volumes were 1712.40 ± 1557.12 mL, 2237.79 ± 1613.34 mL, and 2712.72 ± 1521.19 mL, respectively (p < 0.001). 18(6%) received massive transfusion.The mean gestational age at delivery for these groups was 31.57 ± 6.19, 30.70 ± 6.37, and 30.93 ± 5.91 weeks, respectively, with no statistically significant difference observed (p = 0.33). Detailed perinatal sonographic data were available for 146 women. The associations between each sonographic finding and bleeding volume or gestational age at surgery are presented in Table 3. Table 3Association between sonographic findings and intraoperative blood loss or gestational age at surgery in women with placenta accreta spectrumNumber (%)(146)Bleeding volumeMean ± SD,Median (IQR)p-valueGA at surgeryMean ± SD,Median (IQR)p-valueLoss of the retroplacental clear zone107(73.28)1956.54 ± 1581.75,1450.0 (2350.0)0.7931.26 ± 6.07,34.0 (3.0)0.8739 (26.72)1711.05 ± 1245.38,1250.0 (1900.0)31.39 ± 6.31,33.50 (5.25)Myometrial thinning95(65.06)1837.05 ± 1424.09,1300.0 (2200.0)0.9631.77 ± 5.47,34.0 (3.0)0.7651 (34.94)1901.02 ± 1549.94,1750.0 (2125.0)30.40 ± 7.02,33.50 (6.0)Multiple placental lacunae65(44.50)1973.38 ± 1538.03,1400.0 (2175.0)0.5332.12 ± 4.02,34.0 (2.50)0.9481 (55.50)1832.09 ± 1467.70,1400.0 (2100.0)30.54 ± 7.34,34.0 (5.0)Sub placental hypervascularity125(85.61)1962.56 ± 1542.33,1500.0 (6800.0)0.3031.32 ± 5.87,34.0 (3.0)0.5021 (14.39)1492.85 ± 1129.41,1400.0 (1150.0)30.76 ± 7.57,33.0 (2.0)Exophytic mass3(2.05)3900.0 ± 655.74,4000.0 (-)0.0234.0 ± 1.0,34.0 (2.0)0.41143 (97.95)1852.93 ± 1480.56,1400.0 (6800.0)31.18 ± 6.17,34.0 (3.0)Bladder wall interruption10(6.84)1785.0 ± 1087.31,1750.0 (2250.0)0.8834.10 ± 1.79,34.0 (3.0)0.14136 (93.16)1903.08 ± 1524.31,1400.0 (6800.0)31.03 ± 6.27,34.0 (3.0)Placental bulging8(5.47)2612.5 ± 1390.20,2800.0 (2475.0)0.0833.75 ± 0.70,34.0 (3.0)0.39138 (94.53)1853.40 ± 1495.88,1350.0 (2250.0)31.01 ± 6.26,34.0 (1.0)Bridging vessel44(30.13)2264.77 ± 1745.54,1800.0 (3212.50)0.1431.56 ± 5.56,34.0 (3.0)0.93102 (69.87)1735.49 ± 1352.73,1250.0 (1850.0)31.10 ± 6.36,34.0 (3.0)Assessed by Mann-Whitney testGA, Gestational age Association between sonographic findings and intraoperative blood loss or gestational age at surgery in women with placenta accreta spectrum 1956.54 ± 1581.75, 1450.0 (2350.0) 31.26 ± 6.07, 34.0 (3.0) 1711.05 ± 1245.38, 1250.0 (1900.0) 31.39 ± 6.31, 33.50 (5.25) 1837.05 ± 1424.09, 1300.0 (2200.0) 31.77 ± 5.47, 34.0 (3.0) 1901.02 ± 1549.94, 1750.0 (2125.0) 30.40 ± 7.02, 33.50 (6.0) 1973.38 ± 1538.03, 1400.0 (2175.0) 32.12 ± 4.02, 34.0 (2.50) 1832.09 ± 1467.70, 1400.0 (2100.0) 30.54 ± 7.34, 34.0 (5.0) 1962.56 ± 1542.33, 1500.0 (6800.0) 31.32 ± 5.87, 34.0 (3.0) 1492.85 ± 1129.41, 1400.0 (1150.0) 30.76 ± 7.57, 33.0 (2.0) 3900.0 ± 655.74, 4000.0 (-) 34.0 ± 1.0, 34.0 (2.0) 1852.93 ± 1480.56, 1400.0 (6800.0) 31.18 ± 6.17, 34.0 (3.0) 1785.0 ± 1087.31, 1750.0 (2250.0) 34.10 ± 1.79, 34.0 (3.0) 1903.08 ± 1524.31, 1400.0 (6800.0) 31.03 ± 6.27, 34.0 (3.0) 2612.5 ± 1390.20, 2800.0 (2475.0) 33.75 ± 0.70, 34.0 (3.0) 1853.40 ± 1495.88, 1350.0 (2250.0) 31.01 ± 6.26, 34.0 (1.0) 2264.77 ± 1745.54, 1800.0 (3212.50) 31.56 ± 5.56, 34.0 (3.0) 1735.49 ± 1352.73, 1250.0 (1850.0) 31.10 ± 6.36, 34.0 (3.0) Assessed by Mann-Whitney test GA, Gestational age Nine patients required re-admission due to deep vein thrombosis (1), hematuria (1), internal bleeding (1), ureteral stent removal (3), ureteroscopy (2), and vesicovaginal fistula (1). Neonatal outcome Overall, 83.7% of the neonates survived, and the majority (74.7%) required admission to the neonatal intensive care unit (NICU). The mean birth weight was 2076.56 ± 685.92 g. The mean Apgar score at the first minute was 6.37 ± 2.08 (range: 0–9), and at the fifth minute 8.30 ± 1.37 (range: 3–10). The duration of NICU stay ranged from 0 to 75 days, with a mean of 12.34 ± 13.00 days. Neonatal characteristics and outcomes are shown in Table 4. Table 4Descriptive analysis of neonatal outcomeVariableNumber (%)GA at delivery(week)(n(%)) <24 36(12) 24-33102(34) 34-36148(49.3) ≥3714(4.7)Birth status (n(%)) Alive251 (83.7) Dead49(16.3)Sex(n(%)) Female131(43.7) Male137(45.7) Missing32(10.6)NICU admission (n(%))224(74.7)Reason for NICU admission(n(%)) Prematurity ± RDS197(65.6) Low Apgar10(3.3) Maternal cause9(3) Sepsis3(1) others5(1.7)1st minute Apgar score(n(%)) 0–579(26.3) 6–10180(60)5th minute Apgar score(n(%)) 0–59(3) 6–10250(83.3)NICU Neonatal Intensive Care Unit, RDS Respiratory Distress Syndrome Descriptive analysis of neonatal outcome NICU Neonatal Intensive Care Unit, RDS Respiratory Distress Syndrome Comparison between two study periods We compared the clinical, operative, and perinatal outcomes between the two study periods. Our previous study [11], conducted from January 2015 to October 2019, and a total of 198 women diagnosed with placenta accreta spectrum disorders underwent hysterectomy. Table 5 presents the details of this comparison. Table 5Comparison of maternal and neonatal characteristics and outcomes between two consecutive five-year periods of placenta accreta spectrum management (2015–2019 vs. 2020–2024)VariableFirst 5 yearsN = 198Second 5 yearsN = 300p-valueMaternal age )years)(Mean ± SD)Median (IQR)32.81 ± 4.9832.0 (8.0)34.67 ± 4.3835.0 (6.0)< 0.001*Gravidity (Mean ± SD)Median (IQR)3.67 ± 1.593.0 (1.0)3.87 ± 1.564.0 (2.0)0.10*Live (Mean ± SD)Median (IQR)1.89 ± 1.042.0 (1.0)2.13 ± 1.082.0 (2.0)0.01*Abort (Mean ± SD)Median (IQR)0.58 ± 0.820 (1.0)0.69 ± 1.10 (1.0)0.54*Dead (Mean ± SD)Median (IQR)0.24 ± 0.560 (0)0.17 ± 0.50 (0)0.17*Post op hospital stay(days)(Mean ± SD)Median (IQR)4.4 ± 2.64.0 (2.0)3.74 ± 2.253.0 (3.0)< 0.001*PC transfusion(bags)(Mean ± SD)Median (IQR)2.97 ± 2.192.0 (2.0)3.79 ± 3.203.0 (3.0)0.06*FFP(bags)(Mean ± SD)Median (IQR)4.2 ± 2.464.0 (2.5)4.12 ± 2.284.0 (2.0)0.57*Plt(bags)(Mean ± SD)Median (IQR)4.52 ± 2.684.0 (2.0)4.15 ± 2.274.0 (2.0)0.92*Previous D & C (n(%))0.9** 0172(87)255(85) 123(11.5)38(12.7) 23(1.5)6(2) 301(0.3)GA at diagnosis(n(%))< 0.001** < 14 weeks8 (4.7)15(5) 14–28 weeks31 (18.1)128(42.7) > 28 weeks132 (77.2)157(52.3)GA at surgery(week)(n(%))< 0.001** < 2417 (8.6)36(12) 24–3337 (18.7)102(34) 34–3692 (46.5)148(49.3) ≥ 3752 (26.3)14(4.7)Blood loss(ml)(n(%))46(23)105(35)< 0.001** 1000–200059(29.7)76(25.3) 2000–300047(21.3)30(10) ≥ 300051(25.4)89(29.7)Complications during surgery(n(%))0.009** Bladder injury32(16.7)69(23) Ureter injury2(1)13(4.3) Bladder and ureter injury01(0.3) Bowel injury01(0.3)NICU admission (n(%))113(61.7)224(74.7)< 0.001**1st minute Apgar(n(%))0.1** 0–545(22.7)79(26.3) 6–10149(75.3)180(60)5th minute Apgar (n(%))< 0.001** 0–524(12.2)9(3) 6–10170(85.8)250(83.3)*Assessed by Mann-Whitney test, ** Assessed by Chi-Square test. A p-value less than 0.05 is significant. Mean ± SD; N (%) Comparison of maternal and neonatal characteristics and outcomes between two consecutive five-year periods of placenta accreta spectrum management (2015–2019 vs. 2020–2024) Maternal age )years)(Mean ± SD) Median (IQR) 32.81 ± 4.98 32.0 (8.0) 34.67 ± 4.38 35.0 (6.0) Gravidity (Mean ± SD) Median (IQR) 3.67 ± 1.59 3.0 (1.0) 3.87 ± 1.56 4.0 (2.0) Live (Mean ± SD) Median (IQR) 1.89 ± 1.04 2.0 (1.0) 2.13 ± 1.08 2.0 (2.0) Abort (Mean ± SD) Median (IQR) 0.58 ± 0.82 0 (1.0) 0.69 ± 1.1 0 (1.0) Dead (Mean ± SD) Median (IQR) 0.24 ± 0.56 0 (0) 0.17 ± 0.5 0 (0) Post op hospital stay(days)(Mean ± SD) Median (IQR) 4.4 ± 2.6 4.0 (2.0) 3.74 ± 2.25 3.0 (3.0) PC transfusion(bags)(Mean ± SD) Median (IQR) 2.97 ± 2.19 2.0 (2.0) 3.79 ± 3.20 3.0 (3.0) FFP(bags)(Mean ± SD) Median (IQR) 4.2 ± 2.46 4.0 (2.5) 4.12 ± 2.28 4.0 (2.0) Plt(bags)(Mean ± SD) Median (IQR) 4.52 ± 2.68 4.0 (2.0) 4.15 ± 2.27 4.0 (2.0) *Assessed by Mann-Whitney test, ** Assessed by Chi-Square test. A p-value less than 0.05 is significant. Mean ± SD; N (%) Data for the 2015–2019 period were obtained from the same institutional database and retrospectively analyzed as part of the present study, allowing comparison with cases managed between 2020 and 2024. Discussion PAS represents one of the most challenging obstetric conditions, associated with significant maternal morbidity and mortality due to severe hemorrhage, surgical complications, and the frequent need for hysterectomy. The incidence of PAS has increased globally in parallel with rising cesarean delivery rates, highlighting the importance of early diagnosis and multidisciplinary management. In our five-year study, we analyzed 300 confirmed cases of PAS, providing one of the largest single-center datasets from a tertiary referral hospital. This comprehensive analysis offers valuable insight into the evolving clinical characteristics, management strategies, and outcomes of PAS in our institution. Compared with our previous five-year report, we observed notable improvements in antenatal detection, operative planning, and perinatal outcomes, reflecting enhanced diagnostic vigilance and refined surgical coordination. The lower number of PAS cases observed in 2021 likely reflects the impact of the COVID-19 pandemic on healthcare services and referral patterns, which may have reduced the referral of high-risk pregnancies to our tertiary center during that year. The relatively high cesarean section rate reflects the fact that our institution functions as a tertiary referral center managing a large proportion of high-risk pregnancies, including women with previous cesarean deliveries, placenta previa, suspected PAS, and other obstetric complications requiring operative delivery. In our study, the majority of women had a history of previous uterine surgery, predominantly cesarean section, with only 2.7% of participants having no prior surgical history. This finding aligns with a recent systematic review and meta-analysis reporting that 76.1% (95% CI, 52.4–93.4%) of affected women had undergone previous uterine surgery, most commonly cesarean delivery [12]. Such evidence reinforces the strong association between prior cesarean section and the development of PAS, underscoring the growing clinical significance of surgical history in obstetric management, particularly in regions with increasing cesarean rates. The underlying pathophysiological mechanisms of PAS, while not yet fully elucidated, are thought to be closely related to prior uterine trauma. The most widely accepted theory—the “decidual defect” hypothesis—suggests that uterine surgeries disrupting the endometrial–myometrial interface lead to defective decidualization at the scar site. This abnormal healing process allows the anchoring villi of the placenta to attach to or invade the myometrium directly [13, 14]. Supporting evidence shows that most PAS patients have a history of procedures disrupting the uterine cavity, including cesarean section, myomectomy, hysteroscopic operations, or dilation and curettage [13, 15]. In our cohort, the mean gestational age at delivery was 31 weeks, which is earlier than the recommended 34–36 weeks for planned delivery in PAS. It is important to note that the planned delivery window for patients with suspected PAS in our institution is 34–35 + 6 weeks of gestation; however, a substantial proportion of cases required earlier, unplanned delivery due to emergent obstetric complications, including placenta previa with significant bleeding, preterm labor, preterm premature rupture of membranes, and other maternal or fetal indications. These emergency surgeries accounted for much of the earlier gestational age at delivery and were the main drivers of the higher NICU admission rate secondary to prematurity. Over the five-year study period, 18.3% of our cases required emergency surgery, representing a marked decline compared with our previous report, in which nearly two-thirds of patients underwent emergency operations [11]. This reduction likely reflects the substantial improvement in our prenatal diagnostic capabilities and the implementation of more vigilant antenatal follow-up for high-risk pregnancies. Early recognition of PAS has enabled better planning of delivery timing, multidisciplinary preparedness, and reduced need for emergent intervention. Similarly, a recent systematic review and meta-analysis including 11 studies reported that emergency cesarean delivery occurred in 36.2% (95% CI, 28.1–44.9) of pregnancies complicated by PAS, with 80.3% of these cases (95% CI, 36.5–100.0) occurring before 34 weeks of gestation [16]. The lower rate of emergency operations in our cohort therefore suggests improved antenatal detection and optimized timing of delivery in specialized centers. In our cohort, 76% of patients required blood transfusion, reflecting the high hemorrhagic burden characteristic of PAS disorders. Consistent with previous reports, PAS is commonly associated with large and variable intraoperative blood loss, with published series describing median estimated blood loss of approximately 2–3 L and extremes reaching up to 20 L [17–19]. Transfusion requirements in the literature are similarly high, ranging from 60% to 90%, depending on case severity, management strategy, and availability of multidisciplinary care [20–22]. In a 110-patient series, 78.2% required at least one unit of packed red blood cells (PRBCs), while other single-center cohorts with high rates of placenta previa have reported transfusion frequencies approaching 90% [20, 21]. Mean PRBC use per case has been reported as 4–6 units, emphasizing the need for massive transfusion protocols and early blood bank coordination during operative management of PAS [23]. In our study, blood loss and transfusion needs were greatest among women with placenta percreta, followed by increta and accreta, aligning with prior evidence that the depth of trophoblastic invasion directly correlates with hemorrhagic morbidity [17, 24–26]. Cases of percreta, particularly those involving bladder or serosal invasion, disproportionately contribute to massive hemorrhage events exceeding 3,500 ml and are more frequently associated with unplanned hysterectomy, intensive care admission, and longer operative times [17, 25]. Although modern multidisciplinary planning and antenatal diagnosis have reduced hemorrhagic complications, PAS remains a major cause of peripartum blood loss and transfusion, with reported maternal mortality rates ranging from 0% in highly specialized centers to 4.6% in general institutional series [22, 24, 27]. Our findings therefore reinforce the importance of early diagnosis, surgical preparedness, and availability of massive transfusion protocols to mitigate morbidity associated with these high-risk deliveries. Several studies have also highlighted the impact of delivery timing and planning on maternal outcomes in PAS. Women requiring unplanned or emergency delivery have been shown to experience higher maternal morbidity, including greater transfusion requirements and increased intensive care unit admission compared with those undergoing planned procedures [28, 29]. Similarly, a large multinational study reported that although overall hemorrhagic morbidity may be comparable when delivery occurs in experienced centers, emergency delivery is associated with a higher likelihood of maternal intensive care admission [30]. These findings further emphasize the importance of antenatal diagnosis and coordinated multidisciplinary planning to optimize both maternal and neonatal outcomes in PAS. In the present study, bladder injury was identified as the most frequent intraoperative complication among patients with PAS. Although the incidence of surgical complications was higher than in our previous report, this may partly reflect the increased proportion of severe invasion types, as well as more meticulous intraoperative reporting and documentation in recent years. In published series of cesarean hysterectomy for PAS, bladder injury rates have been reported to range between 18% and 24%, while ureteral injury occurs less frequently, in approximately 2–4% of cases [31, 32]. Other vascular and visceral injuries, including those involving the iliac vessels or bowel, have also been described and contribute significantly to operative morbidity and the need for reoperation [33, 34]. Large multicenter cohorts further indicate that overall surgical morbidity in PAS encompasses hemorrhage or transfusion in approximately 60% of patients, bladder injury in 18–24%, ureteral injury in 2–4%, shock in 9–11%, and coagulopathy in 3–7% [31]. In our study, the majority of neonates required admission to the NICU, primarily because of prematurity and its associated complications. This observation aligns with prior evidence indicating that pregnancies complicated by PAS are commonly delivered before term, mainly due to the need for early, planned intervention to reduce maternal risk. A comprehensive systematic review and meta-analysis reported that the average gestational age at delivery among women with PAS was approximately 34.6 weeks, and that more than half of the newborns required NICU admission as a consequence of prematurity-related complications [13]. Similarly, another comparative study demonstrated that infants born to mothers with PAS had significantly lower gestational age and birth weight than those from uncomplicated pregnancies, emphasizing the adverse neonatal impact of early delivery [35]. Collectively, these findings and our results highlight that neonatal morbidity in PAS is largely secondary to iatrogenic prematurity rather than the placental disorder itself. Therefore, careful multidisciplinary planning of delivery timing is essential to achieve the best balance between maternal safety and neonatal outcomes. Although NICU admission rates were higher in the second study period (74.7% vs. 61.7%, p < 0.001), this finding should be interpreted in the context of changes in delivery timing and perinatal management. In the later cohort, PAS was diagnosed earlier and deliveries were more frequently planned at earlier gestational ages, which likely increased the proportion of iatrogenic preterm births requiring precautionary neonatal monitoring. Importantly, indicators of neonatal condition improved, as reflected by significantly better 5-minute Apgar scores in the second period. Therefore, the higher NICU admission rate likely reflects a more proactive neonatal care strategy associated with earlier planned delivery rather than deterioration in neonatal outcomes. When comparing our current findings with those from the previous five-year period [11], several notable trends highlight significant advances in the diagnosis and management of PAS. The number of identified cases increased from 198 to 296. This apparent rise likely reflects multiple factors, including the growing prevalence of cesarean delivery and improved antenatal detection. Additionally, because our institution functions as a tertiary referral center for high-risk pregnancies, the proportion of PAS cases in our cohort may be higher than that observed in the general obstetric population. The increase in cases over time may also partially reflect improved referral patterns and increased recognition of our center as a specialized unit for PAS management. . The timing of diagnosis has shifted markedly toward earlier gestational ages, allowing the majority of patients to undergo planned rather than emergency surgery. In contrast to our earlier cohort, in which a substantial proportion of women remained undiagnosed until term, the current data show a significant reduction in unrecognized cases and a higher frequency of planned deliveries between 34 and 36 weeks of gestation, in accordance with our institutional protocol. Consequently, the rate of emergency operations has decreased, and postoperative hospitalization duration has significantly shortened [36]. Although NICU admissions have increased, this rise primarily reflects the higher proportion of preterm deliveries resulting from scheduled early births rather than deterioration in neonatal outcomes. Correspondingly, the proportion of neonates with 5-minute Apgar scores above 5 improved significantly, likely due to fewer emergency procedures and enhanced perinatal preparedness. A slight increase in intraoperative complications, particularly related to surgical dissection, was observed and may be explained by the greater number of advanced invasion cases now being diagnosed and managed. Overall, these findings demonstrate that earlier diagnosis, systematic surveillance, and multidisciplinary planning have collectively improved the safety and predictability of PAS management, even in the face of its increasing incidence. Strength and limitations The major strength of this study lies in its large sample size collected over a five-year period from a high-volume tertiary referral center, providing a comprehensive overview of PAS management in real-world clinical practice. Another important strength is the direct comparison with data from the preceding five years, allowing for a meaningful assessment of temporal trends, improvements in diagnostic accuracy, and evolving clinical outcomes. The inclusion of detailed maternal and neonatal parameters, as well as stratification by the depth of placental invasion, adds further value by offering granular insight into the spectrum of disease severity and its implications. However, the study also has certain limitations. Its retrospective design may introduce information and selection biases inherent to medical record–based studies. Changes in diagnostic protocols, surgical team experience, and institutional management strategies over time may also confound direct comparisons between the two study periods. Specifically, because our analysis was limited to patients who underwent cesarean hysterectomy, it does not capture cases managed conservatively. In addition, long-term maternal and neonatal outcomes were not assessed, limiting the ability to evaluate lasting effects beyond the immediate peripartum period. Despite these limitations, the large cohort size, longitudinal comparison, and data from a specialized referral setting enhance the robustness and clinical relevance of the findings. The other limitation is that detailed sonographic findings were available for only 146 women, which may have reduced the statistical power to detect associations between specific imaging features and clinical outcomes. Conclusion Over the past decade, significant progress has been achieved in the diagnosis and management of PAS in our center. Earlier antenatal detection, multidisciplinary planning, and adherence to standardized protocols have markedly reduced emergency deliveries and shortened postoperative hospital stays, while improving neonatal outcomes such as higher 5-minute Apgar scores. Although the overall incidence of PAS and the complexity of cases have increased, reflecting both the rising cesarean section rate and enhanced diagnostic vigilance, these advances have translated into safer and more controlled management. Continued emphasis on early recognition, referral to experienced centers, and protocol-driven multidisciplinary care remains essential to further improve maternal and neonatal outcomes in PAS. Acknowledgements The authors would like to thank Shiraz University of Medical Sciences, Shiraz, Iran and also Center for Development of Clinical Research of Namazi Hospital for statistical assistance. Abbreviations Cesarean section Dilation and curettage Gestational Age Intensive care unit Neonatal intensive care unit Placenta accreta spectrum Packed red blood cells Standard deviation Shiraz University of Medical Sciences Authors' contributions Sh.MA, HB, FSH, HV, NA, AH: concept and design. ZSP, KhB, ZO: Acquisition of data. FA: Pathologic evaluation. AMK: statistical Analysis. All authors contribute in writing and editing the draft. All authors approved the final version. Funding None. Data availability All data analyzed during this study are included in this published article. Declarations Ethical approval and consent to participate The study protocol was approved by the Ethics Committee of Shiraz University of Medical Sciences (Approval code: IR.SUMS.MED.REC.1403.454) and was conducted in accordance with the principles of the Declaration of Helsinki. Consent for publication All participants provided consent for anonymous publication of their data. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement All data analyzed during this study are included in this published article.